You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-central geographic atrophy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Optical Coherence Tomography and Microperimetry Biomarker

Active, not recruiting
  • Age-Related Macular Degeneration
  • +2 more
  • Natural history study
  • Basel, Basel-Stadt, Switzerland
    University Hospital Basel
Jul 19, 2023

Geographic Atrophy Trial (BI 771716)

Not yet recruiting
  • Geographic Atrophy
  • BI 771716
  • (no location specified)
Aug 29, 2023

Non-Exudative (Dry) Age-related Macular Degeneration (dAMD) Trial (EG-301, AREDS2 supplements)

Not yet recruiting
  • Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
  • (no location specified)
Jul 27, 2022

Geographic Atrophy Insights (i-GAIN) Natural History Study

Recruiting
  • Dry Age-related Macular Degeneration
  • +6 more
    • Belfast, United Kingdom
    • +11 more
    Mar 22, 2023

    Age-Related Macular Degeneration, Geographic Atrophy Trial in Holon (smaller incision, new generation implantable miniature

    Not yet recruiting
    • Age-Related Macular Degeneration
    • Geographic Atrophy
    • smaller incision, new generation implantable miniature telescope (SING-IMT)
    • Holon, Tel Aviv, Israel
      Wolfson Medical Center
    Jul 3, 2023

    Age-related Macular Degeneration, Geographic Atrophy Trial (VOY-101)

    Recruiting
    • Age-related Macular Degeneration
    • Geographic Atrophy
    • VOY-101
    • Bellaire, Texas
      Retina Consultants of Texas
    Nov 17, 2022

    Macular Degeneration Trial in United Kingdom, United States (BI 754132)

    Terminated
    • Macular Degeneration
    • BI 754132
    • Beverly Hills, California
    • +12 more
    Aug 23, 2022

    Geographic Atrophy Trial in United States (ORACEA®, Placebo)

    Completed
    • Geographic Atrophy
    • Glendale, California
    • +36 more
    Nov 3, 2022

    Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)

    Completed
    Has Results
    • Age-Related Maculopathy
    • +4 more
    • RN6G
    • Placebo
    • Campbell, California
    • +23 more
    May 10, 2022

    Age-Related Macular Degeneration, Geographic Atrophy Trial in United States (smaller incision, new generation implantable

    Recruiting
    • Age-Related Macular Degeneration
    • Geographic Atrophy
    • smaller incision, new generation implantable miniature telescope (SING-IMT)
    • Pasadena, California
    • +7 more
    Aug 5, 2022

    Geographic Atrophy Trial in Worldwide (PRIMA Bionic Vision System)

    Recruiting
    • Geographic Atrophy
    • PRIMA Bionic Vision System
    • Bordeaux, France
    • +20 more
    Oct 18, 2022

    Non Exudative AMD Imaged With SS-OCT

    Active, not recruiting
    • Dry Macular Degeneration
    • SS-OCT imaging
    • Los Angeles, California
    • +4 more
    Mar 8, 2022

    Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

    Completed
    • Geographic Atrophy
    • Macular Degeneration
    • Phoenix, Arizona
    • +77 more
    Mar 17, 2022

    Non Exudative AMD Imaged With SS-OCT- Extension

    Recruiting
    • Dry Macular Degeneration
    • SS-OCT imaging
    • Los Angeles, California
    • +4 more
    Mar 8, 2022

    Dry Age-related Macular Degeneration Trial in Boston (AAVCAGsCD59)

    Completed
    • Dry Age-related Macular Degeneration
    • AAVCAGsCD59
    • Boston, Massachusetts
      Ophthalmic Consultants of Boston
    Mar 30, 2021

    Geographic Atrophy Associated With Age-Related Macular

    Recruiting
    • Age-Related Macular Degeneration
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jul 21, 2022

      Geographic Atrophy and Their Patient Journey in United States

      Not yet recruiting
      • Geographic Atrophy
        • (no location specified)
        May 26, 2023

        Geographic Atrophy Trial in Bellaire, Dallas (OCU410)

        Recruiting
        • Geographic Atrophy
        • OCU410
        • Bellaire, Texas
        • +1 more
        Aug 25, 2023

        Age-related Macular Degeneration (AMD) Trial in Créteil (Dimethyl Fumarate (TECFIDERA™), No active : no treatment)

        Recruiting
        • Age-related Macular Degeneration (AMD)
        • Dimethyl Fumarate (TECFIDERA™)
        • No active : no treatment
        • Créteil, Val De Marne, France
          Centre intercommunal de Créteil
        Aug 2, 2022

        Geographic Atrophy, Age-Related Macular Degeneration Trial in Barcelona (postbiotics (IGENH35.3A), vitamins (AREDS formulation

        Active, not recruiting
        • Geographic Atrophy
        • Age-Related Macular Degeneration
        • postbiotics (IGENH35.3A)
        • vitamins (AREDS formulation and recommended daily dose)
        • Barcelona, Spain
          Institut de la Màcula
        Jun 18, 2022

        ORACLE: A Long-term Follow-up Study to Evaluate Safety and

        Enrolling by invitation
        • Age Related Macular Degeneration (AMD)
        • GT005
        • Reno, Nevada
          Sierra Eye Associates
        Aug 9, 2022

        Macular Degeneration, Age-Related, Geographic Atrophy Trial in United States (FHTR2163)

        Terminated
        • Macular Degeneration, Age-Related
        • Geographic Atrophy
        • Bakersfield, California
        • +51 more
        Nov 22, 2022

        Geographic Atrophy Trial in United States (RO7303359)

        Active, not recruiting
        • Geographic Atrophy
        • Encino, California
        • +12 more
        Dec 12, 2022

        rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

        Completed
        • Age Related Macular Degeneration
        • Bern, Switzerland
        • +1 more
        Nov 28, 2022

        Geographic Atrophy Trial in United States (PEGCETACOPLAN (APL-2))

        Completed
        • Geographic Atrophy
        • PEGCETACOPLAN (APL-2)
        • Bakersfield, California
        • +4 more
        Nov 8, 2021